BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23259638)

  • 21. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
    Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
    Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MEN1 gene analysis in patients with primary hyperparathyroidism: 10-year experience of a single institution for thyroid and parathyroid care in Japan.
    Kihara M; Miyauchi A; Ito Y; Yoshida H; Miya A; Kobayashi K; Takamura Y; Fukushima M; Inoue H; Higashiyama T; Tomoda C
    Endocr J; 2009; 56(5):649-56. PubMed ID: 19461164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype.
    Pieterman CR; van Hulsteijn LT; den Heijer M; van der Luijt RB; Bonenkamp JJ; Hermus AR; Borel Rinkes IH; Vriens MR; Valk GD;
    Ann Surg; 2012 Jun; 255(6):1171-8. PubMed ID: 22470073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity.
    Agha A; Carpenter R; Bhattacharya S; Edmonson SJ; Carlsen E; Monson JP
    J Endocrinol Invest; 2007 Feb; 30(2):145-9. PubMed ID: 17392605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multilevel Annotation of Germline MEN1 Variants of Synonymous, Nonsynonymous, and Uncertain Significance in Indian Patients With Sporadic Primary Hyperparathyroidism.
    Kaur G; Bhadada SK; Santra M; Pal R; Sarma P; Sachdeva N; Dhiman V; Dahiya D; Saikia UN; Chakraborty A; Sood A; Prakash M; Behera A; Rao SD
    J Bone Miner Res; 2022 Oct; 37(10):1860-1875. PubMed ID: 35856247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic parathyroid glands in MEN1: A rare entity?
    Cavalli T; Giudici F; Nesi G; Amorosi A; Santi R; Brandi ML; Tonelli F
    Fam Cancer; 2017 Apr; 16(2):249-256. PubMed ID: 27766445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence After Surgery for Primary Hyperparathyroidism in 517 Patients With Multiple Endocrine Neoplasia Type 1: An Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines study.
    Santucci N; Ksiazek E; Pattou F; Baud G; Mirallié E; Frey S; Trésallet C; Sébag F; Guérin C; Mathonnet M; Christou N; Donatini G; Brunaud L; Gaujoux S; Ménégaux F; Najah H; Binquet C; Goudet P; Lifante JC
    Ann Surg; 2024 Feb; 279(2):340-345. PubMed ID: 37389888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure.
    Nilubol N; Weinstein LS; Simonds WF; Jensen RT; Marx SJ; Kebebew E
    Ann Surg Oncol; 2016 Feb; 23(2):416-23. PubMed ID: 26542588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.
    Falchetti A; Cilotti A; Vaggelli L; Masi L; Amedei A; Cioppi F; Tonelli F; Brandi ML
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):351-7. PubMed ID: 18414463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?
    Skandarajah A; Barlier A; Morlet-Barlat N; Sebag F; Enjalbert A; Conte-Devolx B; Henry JF
    World J Surg; 2010 Jun; 34(6):1294-8. PubMed ID: 20058152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe bone complications of primary hyperparathyroidism in a young patient with the rare verified mutation of
    Eremkina AK; Sazonova DV; Bibik EE; Sheikhova AZ; Khairieva AV; Buklemishev YV; Mokrysheva NG
    Probl Endokrinol (Mosk); 2022 Feb; 68(1):81-93. PubMed ID: 35262299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese.
    Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
    PLoS One; 2016; 11(11):e0166634. PubMed ID: 27846313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p27
    Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
    J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1.
    Kluijfhout WP; Beninato T; Drake FT; Vriens MR; Gosnell J; Shen WT; Suh I; Liu C; Duh QY
    World J Surg; 2016 Dec; 40(12):2964-2969. PubMed ID: 27402205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.